| Robert Stroble, MD | |
|
180 Debuys Rd, Biloxi, MS 39531-4405 | |
| (228) 818-0563 | |
| (228) 818-0519 |
| Full Name | Robert Stroble |
|---|---|
| Gender | Male |
| Speciality | Radiology - Diagnostic Radiology |
| Location | 180 Debuys Rd, Biloxi, Mississippi |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144301375 | NPI | - | NPPES |
| 00122399 | Medicaid | MS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | 16643 (Mississippi) | Primary |
| Entity Name | Sheridan Radiology Services Of Central Florida Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1134567506 PECOS PAC ID: 4688762149 Enrollment ID: O20071116000118 |
News Archive
Merck, known as MSD outside the United States and Canada, and Samsung Bioepis Co., Ltd., announced today that they have expanded their collaboration with an agreement to develop, manufacture and commercialize MK-1293, an insulin glargine candidate for the treatment of patients with type 1 and type 2 diabetes. Phase III clinical studies in type 1 and type 2 diabetes will begin soon.
Uniquely providing totally free access to scientific publications, and offering financial rewards for both authors and peer reviewers
La Soci-t- fran-aise de m-decine d'urgence (SFMU) has chosen Springer to publish its scientific research in a new French journal Annales fran-aises de m-decine d'urgence. Bruno Riou, Professor on the Pierre and Marie Curie Faculty of Medicine at the Sorbonne Universities is editor-in-chief of this official society journal.
The Department of Health and Human Services' Agency for Healthcare Research and Quality today announced grants to support efforts by States and health systems to implement and evaluate patient safety approaches and medical liability reforms. The demonstration and planning grants are part of the patient safety and medical liability initiative that President Obama announced during a September 9, 2009 address to a joint session of Congress.
Nanostart subsidiary MagForce Nanotechnologies AG, a leading medical technology company focusing on nanomedicine in oncology, announced that the Charité-Universitätsmedizin Berlin published the establishment of its NanoTherm therapy center for the treatment of recurrent brain tumors.
› Verified 8 days ago
| Entity Name | Radiology Physician Solutions Of North Florida Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447761101 PECOS PAC ID: 2466710306 Enrollment ID: O20180216001493 |
News Archive
Merck, known as MSD outside the United States and Canada, and Samsung Bioepis Co., Ltd., announced today that they have expanded their collaboration with an agreement to develop, manufacture and commercialize MK-1293, an insulin glargine candidate for the treatment of patients with type 1 and type 2 diabetes. Phase III clinical studies in type 1 and type 2 diabetes will begin soon.
Uniquely providing totally free access to scientific publications, and offering financial rewards for both authors and peer reviewers
La Soci-t- fran-aise de m-decine d'urgence (SFMU) has chosen Springer to publish its scientific research in a new French journal Annales fran-aises de m-decine d'urgence. Bruno Riou, Professor on the Pierre and Marie Curie Faculty of Medicine at the Sorbonne Universities is editor-in-chief of this official society journal.
The Department of Health and Human Services' Agency for Healthcare Research and Quality today announced grants to support efforts by States and health systems to implement and evaluate patient safety approaches and medical liability reforms. The demonstration and planning grants are part of the patient safety and medical liability initiative that President Obama announced during a September 9, 2009 address to a joint session of Congress.
Nanostart subsidiary MagForce Nanotechnologies AG, a leading medical technology company focusing on nanomedicine in oncology, announced that the Charité-Universitätsmedizin Berlin published the establishment of its NanoTherm therapy center for the treatment of recurrent brain tumors.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Robert Stroble, MD Po Box 789, Ocean Springs, MS 39566-0789 Ph: (228) 818-0563 | Robert Stroble, MD 180 Debuys Rd, Biloxi, MS 39531-4405 Ph: (228) 818-0563 |
News Archive
Merck, known as MSD outside the United States and Canada, and Samsung Bioepis Co., Ltd., announced today that they have expanded their collaboration with an agreement to develop, manufacture and commercialize MK-1293, an insulin glargine candidate for the treatment of patients with type 1 and type 2 diabetes. Phase III clinical studies in type 1 and type 2 diabetes will begin soon.
Uniquely providing totally free access to scientific publications, and offering financial rewards for both authors and peer reviewers
La Soci-t- fran-aise de m-decine d'urgence (SFMU) has chosen Springer to publish its scientific research in a new French journal Annales fran-aises de m-decine d'urgence. Bruno Riou, Professor on the Pierre and Marie Curie Faculty of Medicine at the Sorbonne Universities is editor-in-chief of this official society journal.
The Department of Health and Human Services' Agency for Healthcare Research and Quality today announced grants to support efforts by States and health systems to implement and evaluate patient safety approaches and medical liability reforms. The demonstration and planning grants are part of the patient safety and medical liability initiative that President Obama announced during a September 9, 2009 address to a joint session of Congress.
Nanostart subsidiary MagForce Nanotechnologies AG, a leading medical technology company focusing on nanomedicine in oncology, announced that the Charité-Universitätsmedizin Berlin published the establishment of its NanoTherm therapy center for the treatment of recurrent brain tumors.
› Verified 8 days ago
Dr. Mark Burnette Wall, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 150 Reynoir St, Biloxi, MS 39530 Phone: 228-436-1111 | |
Dr. Dianna Andrea Ragula, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 150 Reynoir Street, Biloxi, MS 39530 Phone: 228-436-1254 Fax: 228-436-1289 | |
Richard J Orange, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 180 Debuys Rd, Biloxi, MS 39530 Phone: 228-436-1111 Fax: 228-436-1289 | |
Phil Sykes, Radiology Medicare: Not Enrolled in Medicare Practice Location: 400 Veterans Ave, Biloxi, MS 39531 Phone: 228-523-5436 | |
Dr. Quan Huu Ha, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 400 Veterans Ave, Biloxi, MS 39531 Phone: 228-523-5436 | |
Shaun W Mckee, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 1720c Medical Park Dr, Biloxi, MS 39532 Phone: 228-354-0251 Fax: 228-396-3550 |